UCSF Breakthrough Study Offers Hope for SCN2A Disorders Through EpiEditing Technology Recent UCSF research highlights the potential of CRISPR technology in treating SCN2A disorders, showcasing a promising path for targeted therapies.

UCSF Breakthrough Study Offers Hope for SCN2A Disorders Through EpiEditing Technology #USA #San_Francisco #CRISPR_Technology #SCN2A_Haploinsufficiency #Regel_Therapeutics